GK

Geoffrey Kempler

Hexima Limited | Executive Chairman, Managing Director
Mr Kempler has experience in investment and business development. He served as Chairman and Non-Executive Director of Opthea Limited, an ASX- and NASDAQ-listed drug development company, from November 2015 to October 2020. He was Chairman of AusBiotech, an Australian biotechnology organisation, from November 2021 to November 2023.

Company and Roles

Company
Title
Tenure
Since
HXL
HXL
Hexima Limited
  • Executive Chairman
  • Managing Director
2yrs, 10mthSep 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ATH
ATH
17/09/2530,00018,011,00060,000,000N/A
HXL
HXL
Hexima Limited
30/06/25N/AN/A3,350,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ATH
ATH
17/09/25
Expiry
14,000,000$0.011$154,000Options expired
ATH
ATH
30/12/24
Issued
60,000,000$0.008$480,000Employee Share Ownership Plan
HXL
HXL
Hexima Limited
20/03/24
Issued
3,350,000$0.013$43,550Issue of options
ATH
ATH
14/12/22
Expiry
5,000,000$0.010$50,000Options expired
ATH
ATH
18/09/20
Issued
14,000,000$0.054$756,000Issue of options